Jpmorgan Chase & CO Natera, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Natera, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,632,029 shares of NTRA stock, worth $739 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,632,029

Previous 6,065,819 23.64%

Holding current value

$739 Million

Previous $657 Million 10.37%

% of portfolio

0.05%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	SELL	$97.75 - $129.67 $140 Million - $186 Million	-1,433,790 Reduced 23.64%	4,632,029 $589 Million
Q3 2024 Nov 08, 2024	SELL	$97.75 - $129.67 $140 Million - $186 Million	-1,433,790 Reduced 23.64%	4,632,029 $589 Million
Q2 2024 Dec 26, 2024	BUY	$85.28 - $112.6 $122 Million - $161 Million	1,433,790 Added 30.95%	6,065,819 $657 Million
Q2 2024 Aug 12, 2024	SELL	$85.28 - $112.6 $110 Million - $145 Million	-1,292,097 Reduced 17.56%	6,065,819 $657 Million
Q1 2024 Dec 26, 2024	BUY	$59.21 - $92.9 $161 Million - $253 Million	2,725,887 Added 58.85%	7,357,916 $673 Million
Q1 2024 May 10, 2024	SELL	$59.21 - $92.9 $35.3 Million - $55.4 Million	-596,296 Reduced 7.5%	7,357,916 $673 Million
Q4 2023 Dec 26, 2024	BUY	$37.55 - $62.64 $125 Million - $208 Million	3,322,183 Added 71.72%	7,954,212 $498 Million
Q4 2023 Feb 12, 2024	BUY	$37.55 - $62.64 $14.9 Million - $24.9 Million	397,420 Added 5.26%	7,954,212 $498 Million
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $28 Million - $40.3 Million	644,102 Added 9.32%	7,556,792 $334 Million
Q2 2023 Aug 11, 2023	BUY	$47.08 - $55.16 $12.6 Million - $14.7 Million	267,357 Added 4.02%	6,912,690 $336 Million
Q1 2023 May 18, 2023	BUY	$36.57 - $58.29 $2.22 Million - $3.54 Million	60,777 Added 0.92%	6,645,333 $369 Million
Q1 2023 May 11, 2023	BUY	$36.57 - $58.29 $14 Million - $22.3 Million	381,844 Added 6.16%	6,584,556 $366 Million
Q4 2022 Feb 13, 2023	BUY	$34.17 - $47.91 $21.6 Million - $30.3 Million	632,340 Added 11.35%	6,202,712 $249 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $3.6 Million - $5.53 Million	97,593 Added 1.78%	5,570,372 $244 Million
Q2 2022 Aug 11, 2022	BUY	$28.13 - $44.54 $13.1 Million - $20.8 Million	466,500 Added 9.32%	5,472,779 $194 Million
Q1 2022 May 11, 2022	SELL	$30.32 - $91.33 $2.21 Million - $6.65 Million	-72,812 Reduced 1.43%	5,006,279 $204 Million
Q4 2021 Feb 10, 2022	BUY	$86.26 - $119.0 $30.7 Million - $42.3 Million	355,574 Added 7.53%	5,079,091 $474 Million
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $473 Million - $597 Million	4,723,517 New	4,723,517 $526 Million

Others Institutions Holding NTRA

# of Institutions

527

Shares Held

118M

Call Options Held

308K

Put Options Held

191K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.5B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Natera, Inc. Transaction History